SynDRA canonical compound SYN0006416 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HPRT1 | IMPDH1 | IMPDH2 | PPAT |
| Mechanism of action | immunosuppressant | protein synthesis inhibitor | purine antagonist |
| Indication | acute lymphoblastic leukemia (ALL) |
| Disease area | hematologic malignancy |